The purpose of this study was to determine, from a range of doses, which would evoke limiting pharmacologic response or lesions. This information must be known before starting a carcinogenicity study, in which untoward effects, incompatible with long term survival of the animals, must be avoided.
Procedure
Ten rats per sex group were injected daily in the thigh muscle with the following doses of gold sodium thiomalate: 192 (97), 96 (48.5), 48 (24.2) . 24 (12.l), 12 (6.1), 6 (3). or 3 (1.5) mg/kg/day. In order to achieve the 3 highest doses, the drug was injected undiluted, i.e., as a 5% solution. With the highest dose, a mature rat weighing 0.4 kg received about 1.5 ml at each injection. For the 4 lower dose groups the commercial material was diluted with water to make a 2.5% solution. The control group was injected with sterile water.
The local effects of injection and a detailed description of the renal lesions are reported separately from the systemic toxicity.
Results

Highest Dose Group (192 mg/kg)
During the first week the body weights were about 40% below the controls; half of the rats died. Further deaths occurred during the second month of dosing, so that when by day 57 only 5 rats remained, they were killed for autopsy.
In the rats that died during the first week, there were 3 main lesions: (1) degeneration and necrosis of the proximal tubular epithelial cells of the kidneys, (2) accumulation of a golden pigment in macrophages around the acini of the exocrine pancreas, and (3) myositis, myodegeneration and fibrosis at the site of injection.
In the rats killed on day 57, prominent gross lesions occurred in the kidney, the pancreas and at the site of injection. The kidneys were pale and 2 to 3 times normal size. On the cut surface the cortex was enlarged and pale. Histologically, there was a loss of the tubular epithelium and marked fibrosis and pigmentation. The few remaining tubules were dilated.
The pancreas was either yellow or gray. Histologically, the acini of the exocrine 23 pancreas were lost while the islets of Langerhans were intact. Some normal acini remained in some rats while in others all of the acini were lost. The yellow color seen grossly was correlated with the accumulation of golden pigment in macrophages around the acini. The gray color correlated with loss of the acinar pancreas. Accumulation of golden, birefiingent pigment was most prominent in the pancreas and kidney but macrophages throughout the body also contained it. (A histochemical test of this pigment is mentioned on page 34). The amount of pigment in an organ seemed to be directly related to the number of macrophages normally present. The lymph nodes, especially those located close to the injection sites, always contained heavily laden macrophages (Figs. 14-19 ). The spleen was less prominently affected. Often the Kupffer cells of the liver contained the pigment but in less dense accumulations than the aforementioned sites (Figs. 10, 11 ). The bone marrow also contained pigment-laden macrophages (Figs. 12, 13) . The serosa covering visceral organs often contained pigment-laden macrophages (Fig. 8 ) even when the organ was unaffected. In a few rats the subcutaneous tissue and the lamina propria of the colon contained the pigmented macrophages. Slight golden pigmentation often occurred in a few macrophages in the ovarian stroma, between the tubules of the testicles, between the myofibers of the heart, around major vessels of the lungs and bronchi and sometimes around the acini of salivary glands.
The legs of some rats becamequite enlarged, with red, black or yellow masses. Histologically, there were necrosis, myositis, fibrosis and acute hemorrhage. 
% mg/kg Dose Group
The average body weight was about 25% below the controls by the end of the first week and remained so thereafter.
Although only 8/20 rats had died by day 112, the remaining rats were killed and autopsied to spare them further pain produced by the injections.
The consistent gross lesions at autopsy were: (I) yellow discoloration of the pancreas (Fig. l) , (2) pale gray to white, enlarged kidneys with numerous small cysts in the cortex (Fig. I) , and (3) red and yellow masses in the hind legs at the site of injection. Also, some lymph nodes in some rats were enlarged and gray or yellow.
The terminal lesion in those rats that died was renal. It is described and illustrated in a subsequent paper @. 52) and will therefore be touched on only briefly here. Histologically, the cortex contained predominantly fibrous connective tissues, prominent pigment and crystals and a few dilated tubules lined with regenerated epithelium. The glomeruli were normal and there were no infiltrates of lymphocytes or plasma cells.
Blood urea nitrogen (BUN) values determined on samples collected within one day of autopsy from 5 females and 8 males were 148, 147, 145, 29 and 23 mg% for the females and 49, 47, 39, 35, 34, 32, 29 and 18 mg% for the males. The normal range in our laboratory for female rats is 13.1 to 41.5 mg% and for males is 12.9 to 35.8 mg%. The first 3 females listed had essentially no normal tubules in their kidneys. In the rats autopsied on day 122, the amount of fibrosis was correlated with the BUN value. The male with a BUN of 49 mg% had a moderate amount of fibrosis and the one with a BUN of 18 mg% had an essentially normal kidney. The changes in the abnormal kidneys of rats without markedly elevated BUN'S were characteristics of "polycystic kidneys", i.e. many dilated tubules lined with regenerated epithelium.
The extensive renal fibrosis is considered to be due to the drug because the lesion is dissimilar to any we have observed in untreated control rats. While no control rats died in this study during the first 112 days, i.e., we have no histologic material for comparison at this period, it may be assumed that their kidneys were unaffected. This is because the kidneys from 7 control rats which died or were killed subsequently, up to day 583, had no cortical fibrosis. Further, we have encountered no report in the literature of a similar lesion arising naturally in untreated rats.
The grossly yellow discoloration of the pancreas was seen histologically to be due to marked accumulation of a birefringent golden pigment as in the previous group. The amount of pigment varied between rats, but each pancreas always contained more pigment than any other tissue except the injection sites. The pigment appeared to first accumulate around the basement membranes of the pancreatic acini (Fig. 5) . The acinar epithelial cells underwent degeneration and then the lobule became fibrotic (Figs. 3, 4) . The accumulation of pigment, degeneration and fibrosis had a lobular distribution (Fig. 2) . Pigment was also prominent in macrophages (Fig. 9 ). The amount of acinar damage varied between rats from a few fibrotic lobules to almost complete destruction of the exocrine tissue (Figs. 6 9 ) , but the endocrine pancreas was not affected (Fig. 7) . The area of the injection site was severely damaged in this group of rats. There was a progressive muscle degeneration and fibrosis. The fibrous granulation tissue contained many pigment-laden macrophages. Usually hemorrhage or a hematoma was seen in the area.
mg/kg Dose Group
The body weight was about 15% below the controls at the end of the first week. The females then returned to the same weight as the controls whereas the males remained 15 to 20% below the controls.
Although only 4 rats (39 and IS) had died, the remainder were killed on day 212 to spare them further pain from the injections.
The death of the first 2 rats examined post mortem was not attributed to the drug. The first of these, which died on day 154, had a sanguinopurulent prostatitis and cystitis. The second one was killed on day I16 because she had become belligerent and difficult to dose.
The other 2 that came to autopsy before day 212 had lesions considered to be treatment related. The one examined on day 182 had a BUN of 670 mg% and enlarged parathyroids. The one examined on day 203 was emaciated, severely anemic and had a BUN of 435 mg%, gastritis, enlarged parathyroids and osteomalacia. Both had severe chronic nephritis leading to uremia and a marked accumulation of pigment in the pancreas, with destruction of most of the acini.
In the 16 rats (79 and 98) autopsied on day 212, gross lesions were in the kidney, pancreas and at the injection site. The kidneys varied from normal to quite pale and moderately enlarged. The pancreas varied from normal to yellow. The injection site had edematous swellings with dark red or white areas.
Histologically, the kidneys of all of the rats had cortical fibrosis and/or accumulations of lymphocytes and plasma cells as in the previous groups. Also, there were regenerated tubular epithelial cells, thickened basement membranes, dilated tubules and karyomegaly of the cortical tubular epithelium. The latter change was more prominent in the females. The changes in tubular epithelium considered to be preneoplastic were first seen in this group. (They are described in a separate paper, p.
82).
The kidneys from the rat which died on day 203 were subjected to a histochemical test for gold (Elftman)'. A strongly positive reaction occurred.
As in the previous groups, a preferential accumulation of pigment was discerned in the pancreas. Three males had fibrosis of lobules of the acinar pancreas and 2 others had slight degeneration of acinar cells. Thus, 5/9 males and none of the 7 females had pancreatic acinar damage, i.e., considerably less than in the rats in the 96 mg/kg dose group.
Histologically, the injection site had severe acute and chronic inflammation, hemorrhage and often numerous pigment-laden rnacrophages. The acute inflammatory reaction (edema, fibrin, neutrophils, lymphocytes) often extended between muscle fibers. The prominent chronic inflammatory reaction consisted of bands of dense, fibrous connective tissue often containing vascular channels, capillary proliferation and regions of loose myxomatous connective tissue.
The accumulation of a golden yellow pigment in macrophages throughout the body occurred as in the higher dose groups, but generally to a lesser extent.
mg/kg Dose Group
The body weights of the females were about 10% below that of the controls at the end of the first week. They returned to control values thereafter, and remained the same until about week 30. From then until autopsy of the group, their weight was about 10% below that of the controls. Surprisingly, 9/10 males but no females, died in the first 4 days. The reason for the apparent inconsistency is not known. (No deaths occurred in the first week with 48 mg/kg, and only 1 death at 96 mg/kg.) In 2 of these males coagulative necrosis of the renal tubular epithelium in the inner medulla was considered to be the cause of death. In the other 7 postmortem autolysis precluded a diagnosis.
Three females came to autopsy before the remainder were killed on day 358. One which died on day 233 was severely anemic, a condition not ascribed to the treatment. Another one was killed on day 283 because of a markedly swollen right rear leg and foot, probably consequent to the injections. One died on day 296 from severe chronic nephritis, which was considered to be due to the treatment.
The remaining 7 females and 1 male were autopsied on day 358. They had moderate karyomegaly of the renal tubular epithelial cells, a change due to the drug treatment. They also had slight to moderate chronic nephritis. The lesions were qualitatively the same as those of the common chronic nephritis of old rats. However, their incidence was higher than in the controls. The BUN of each was in the normal range.
Drug-related neoplasia occurred first in this group. A female killed on day 358 had a renal adenoma and a fibroma at the injection site in the rear leg. Two others had a fibroma in a rear leg. The rear legs in all rats had severe chronic myositis, fibrosis, hemorrhage and many pigmented macrophages at the injection site.
Degeneration of the exocrine pancreas was not seen in any rats in this dose group. Pigmented macrophages occurred throughout the body at common sites of macrophages, but to a lesser extent than seen with higher doses.
After about 3 months of dosing, these rats gained less weight than the controls, so that by the time of autopsy the group average was about 25% less than the controls.
Except for 1 male that died on day 4, no deaths occurred until day 262. Thereafter rats in moribund condition were killed for autopsy on days 262, 400, 444, 455, 485, 520 and 534. A male killed on day 262 and another male on day 400 had renal cortical fibrosis and secondary hyperparathyroidism. A male killed on day 444 had a renal carcinoma metastatic to the liver and lungs. A female (the only one killed before the entire group was killed) had a mammary adenocarcinoma and a responsive anemia, probably due to hemorrhage from the ulcerated adenocarcinoma. Histologically, a renal cortical adenoma was found. A lethargic, ataxic male was killed on day 485 and no basis for the clinical illness was found. Two males were killed on days 520 and 533 because of a sarcoma at the injection site. Because of the high mortality in the males, the remaining 12 (99 and 3 4 rats were killed for autopsy on day 583. Renal neoplasms were found grossly in 3/9 females and 2/3 males. By histologic examination of 2 sections from one kidney a renal adenoma was found in 4 other females. Thus renal adenomas were found in 7/9 females and 2/3 males autopsied on day 583. Adding those that were found before day 583, adenomas occurred in 8/10 females and 3/9 males in the 12 mg/kg dose group. (The male that died on day 4 is not included). Marked karyomegaly of the renal cortical tubular epithelium occurred in all of these 12 rats.
The body weights of this group were about the same as those of the 12 mg/kg dose group, i.e., their weight gradually became less than controls so that after the first year their weights were about 13% below them.
A male rat died on day 156 from malignant lymphoma. Another male died on day 190, of undetermined cause. A female was killed on day 4 I6 because of red, severely swollen eyes. (Several other rats were similarly but less severely affected). Histologically an inflammation of the anterior ocular segment, with bacteria in the neutrophils was seen. A microscopic adenoma was seen in the renal cortex. A female died on day 503 and the cause was not determined.
A firm, mid-abdominal mass was palpated on day 506 in a female. She was killed for autopsy on day 507 and had a renal carcinoma which had spread to adjacent organs and metastasized to the lungs. Another female was killed for autopsy on day 519 because of a large mammary adenoma. A renal cortical adenoma was found histologically.
A male developed abdominal distension on day 546 and was killed on day 548. He had chronic peritonitis due to spreading of a renal carcinoma that had destroyed one kidney.
Another male was killed on day 583 because he had lost weight and was anemic and uremic. He had pale polycystic kidneys grossly and renal cortical fibrosis histologically.
A female with a markedly distended abdomen was killed on day 640. She had a renal tumor that had spread throughout the thoracic cavity. A male with a distended abdomen, killed on the same day, did not have a renal tumor but rather a markedly distended urinary bladder presumably due to a urethral blockage.
A male was found dead on day 655. He had a large tumor destroying most of one kidney, a small tumor in the other kidney as well as chronic nephritis. He probably died from uremia.
A female that died on day 674 had a small adenoma in the renal cortex but chronic cystic nephritis was probably the cause of death.
A female was autopsied on day 687 and no renal tumor was seen. A male was found dead on day 697. He had a renal adenoma that extended across the cortex.
A male was found dead on day 699 that had a large adenocarcinoma of the renal cortex with extension throughout the abdominal cavity and metastatic nodules filling the lungs and bronchial lymph nodes. A female died on day 700 and a male was killed on day 734; both had chronic cystic nephritis.
The remaining 2 females and 1 male were killed on day 748. All had renal adenomas.
In this group, 12 (7 females, 5 males) of 18 rats developed renal tumors. Two of the original 20 died before reaching a susceptible age.
The rats gained weight slightly less than the controls. The females were 5 % below the controls after 2 months of dosing and 10% below by week 40. The males were 5% below the controls after 34 weeks of dosing, 10% below after 45 weeks.
Three rats (2 females, 1 male) each died on day 380, 416 or 421 from natural disease unrelated to treatment.
On day 523, a male was autopsied that had a papillary adenoma extending through the renal cortex. On each of days 526 and 540 a male was found dead but without any renal tumor.
On day 562, a male with a large mass in the right rear leg at the injection site was killed. The mass was a fibrosarcoma (described separately). No renal tumor was found.
On day 594, a female was killed because she had a large mammary tumor. She had an early adenoma in the renal cortex that was cystic and filled with pink proteinaceous material.
A female was found dead on day 617, but no gross evidence of a renal tumor was seen. Another female killed in moribund condition on day 633 had chronic nephritis but no renal tumor.
On day 677 a male rat was found dead. He had a large adenocarcinoma that had destroyed most of one kidney and a microscopic adenoma in the other kidney. On day 685, another male was found dead that had a very similar large tumor in one kidney and a small one in the other kidney. On day 693 a moribund female was killed. She had an adenoma replacing most of one kidney, a tumor at the injection site of one leg and a thrombus partially occluding the left auricle. The latter was apparently the cause of the moribund condition.
On day 707, a moribund female was killed. She had a large cystic adenoma that had destroyed one kidney. On day 727, a male was found dead. He had a cystic adenoma extending across one-half of the cortex of a kidney. A female died on day 74 1 with renal adenocarcinoma.
On day 748, the 4 remaining rats (2 females, 2 males) were killed. One male had a renal adenoma.
Thus, 9 (4 females, 5 males) of the 20 rats developed renal tumors. One developed a fibrosarcoma at the injection site.
Control Group
Renal tubular cell cytomegaly or karyomegaly did not occur in any control rat. Neoplasia of the kidney was not found in any control rat.
Chronic nephritis was the most common cause of death in the control rats. Cystic dilation of tubules was common but the diffuse interstitial fibrosis characteristic of certain drug-treated rats was not seen.
No rat had any pancreatic lesion like that seen with high doses of gold sodium thiomalate.
One male rat killed on day 748 had a 6 cm diameter irregularly-shaped tumor at the injection site in the rear leg. Histologically, it appeared to be a fibrosarcoma.
Discussion
Degeneration of the pancreatic acinar cells occurred in the rats injected with 48 mg/kg/day and higher dosages. The initial change appears to be the accumulation of a golden yellow pigment on the basement membranes around the acinus. Then the acinar epithelial cells undergo degeneration and necrosis. The framework of the acinus then collapses, phagocytosis of pigmented material occurs and fibrosis develops. During the developmental stages, the pancreas is grossly yellow but in the end stage it is gray.
Atrophy of the exocrine pancreas in rats has been reported in chronic intoxication with cadmium.' The lesion was produced with 100 ppm or more of cadmium in the drinking water for 37 weeks. In our study the pancreatic lesion occurred with 48 mg/kg/day and higher doses.
The occurrence of 0/20,9/20 and 12/ 18 renal tumors in the control, 3 mg/kg, and 6 mg/kg groups, respectively, is indicative of a dose response. The occurrence of renal tumors in 8/10 females by day 583 in the 12 mg/kg dose group is added indication of a dose response. The males in this group and both sexes at higher doses died too early to allow comparison.
Conclusion
The daily injection of rather high doses of gold sodium thiomalate resulted in degeneration and fibrosis of the acinar pancreas and acute tubular degeneration of the renal cortex. Lower doses for a longer time produced renal tubular cell karyomegaly and cortical fibrosis. Long-term administration produced renal tubular cell neoplasia and sarcomas at the injection site.
